Comprehensive Financial Consultants Institutional Inc. Buys 28 Shares of Stryker Corporation $SYK

Comprehensive Financial Consultants Institutional Inc. lifted its holdings in Stryker Corporation (NYSE:SYK) by 0.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,546 shares of the medical technology company’s stock after acquiring an additional 28 shares during the quarter. Comprehensive Financial Consultants Institutional Inc.’s holdings in Stryker were worth $1,799,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of SYK. Brighton Jones LLC lifted its holdings in Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares in the last quarter. Vest Financial LLC acquired a new position in shares of Stryker in the 1st quarter valued at $203,000. Procyon Advisors LLC lifted its stake in shares of Stryker by 2.3% in the 1st quarter. Procyon Advisors LLC now owns 2,611 shares of the medical technology company’s stock valued at $972,000 after purchasing an additional 59 shares during the period. SeaCrest Wealth Management LLC lifted its stake in shares of Stryker by 27.6% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,497 shares of the medical technology company’s stock valued at $557,000 after purchasing an additional 324 shares during the period. Finally, Sivia Capital Partners LLC lifted its stake in shares of Stryker by 4.0% in the 1st quarter. Sivia Capital Partners LLC now owns 1,070 shares of the medical technology company’s stock valued at $398,000 after purchasing an additional 41 shares during the period. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Ronda E. Stryker sold 200,000 shares of the firm’s stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the completion of the transaction, the director owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Viju Menon sold 500 shares of the firm’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the transaction, the insider owned 12,511 shares of the company’s stock, valued at $4,886,921.71. The trade was a 3.84% decrease in their position. The disclosure for this sale can be found here. 5.20% of the stock is owned by company insiders.

Analysts Set New Price Targets

SYK has been the subject of a number of recent analyst reports. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. Weiss Ratings restated a “buy (b-)” rating on shares of Stryker in a research report on Saturday, September 27th. Needham & Company LLC upped their price objective on shares of Stryker from $442.00 to $448.00 and gave the company a “buy” rating in a research report on Friday, August 1st. Redburn Partners set a $420.00 price objective on shares of Stryker in a research report on Thursday, September 18th. Finally, BTIG Research restated a “buy” rating on shares of Stryker in a research report on Monday, July 14th. Fifteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $430.33.

Stryker Price Performance

SYK stock opened at $370.59 on Monday. The stock has a 50-day moving average price of $382.81 and a two-hundred day moving average price of $378.96. The stock has a market cap of $141.68 billion, a PE ratio of 49.08, a price-to-earnings-growth ratio of 2.67 and a beta of 0.94. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.06. The company had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter last year, the company earned $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Equities analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a $0.84 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker’s dividend payout ratio (DPR) is presently 44.50%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.